Clinical Trial Update: Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing imiquimod to photodynamic therapy for actinic keratoses in organ transplant recipients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratoses

Drugs mentioned

• Imiquimod (imiquimod)
• Photodynamic Therapy

Snippet

Sponsor: Medical University of Vienna | Conditions: Actinic Keratoses | Phase 4 | Status: TERMINATED